CTLA4 and colorectal carcinoma: Given the pivotal impact of these molecular alterations in defining the CRC immune landscape, it is likely that they also shape the activity of additional checkpoint axes beyond the canonical PD-1/PD-L1 and CTLA-4 pathways.